ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Articles

Single-dose flu drug approved for sale in Japan

Shionogi's virus-suppressing medication to rival Tamiflu

It is hoped that Xofluza can bring down the costs of flu treatment and help control the spread of infection.

TOKYO -- A drug that suppresses replication of the flu virus with a single oral dose has been approved for sale in Japan.

Japanese drugmaker Shionogi on Friday announced that its Xofluza tablet had received approval from the Ministry of Health, Labour and Welfare.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close